Skip to content

Study on Vallarai nei (Internal) and Sembarithipoo Ennai for the treatment of Kalanjaga padi in children

Clinical evaluation of Vallarai nei(Internal) and Sembarithipoo Ennai (external) for the management of Kalanjaga padai (Psoriasis) in Children

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026154
Enrollment
30
Registered
2020-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: vallarai nei Sembarithipoo ennai: Vallarai nei is a polyherbal formulation 5 to 8 ml bd for 5 to 12 years children for 45 days Sembarithipoo ennai is a polyherbal formulation for exter

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with Erythema Thickness Scaling With or without Intching auspitz sign positive candle crease sign positive

Exclusion criteria

Exclusion criteria: Eczema Psoriatic arthritis fungal infections Eplepsy Lesions with secondary infection

Design outcomes

Primary

MeasureTime frame
Efficacy of the trial drug is measured by PASI score and improvement in the clinical condition assured by reducing the degrees of involvent of the body region from 5 to 1Timepoint: 12 months

Secondary

MeasureTime frame
Reduction in the remission of the disease and improvement in the quality of life in childrenTimepoint: 45 days

Countries

India

Contacts

Public ContactDr K Vennila

National Institute of Siddha

gvennils@gmail.com9789093986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026